Billiontoone (NASDAQ:BLLN) Sets New 1-Year Low – What’s Next?

Billiontoone, Inc. (NASDAQ:BLLN) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $80.00 and last traded at $80.57, with a volume of 134914 shares traded. The stock had previously closed at $85.95.

Analyst Ratings Changes

A number of brokerages have recently issued reports on BLLN. BTIG Research reaffirmed a “buy” rating and issued a $160.00 price objective on shares of Billiontoone in a research note on Wednesday, December 10th. William Blair began coverage on Billiontoone in a research note on Monday, December 1st. They issued an “outperform” rating for the company. Stifel Nicolaus assumed coverage on shares of Billiontoone in a research report on Monday, December 1st. They set a “buy” rating and a $145.00 price target for the company. Zacks Research upgraded shares of Billiontoone to a “hold” rating in a report on Tuesday, December 2nd. Finally, JPMorgan Chase & Co. cut their price target on Billiontoone from $150.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, December 10th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Billiontoone currently has a consensus rating of “Moderate Buy” and a consensus price target of $135.29.

Billiontoone Trading Down 2.1%

The stock has a market capitalization of $3.85 billion and a price-to-earnings ratio of 841.10. The company’s 50 day simple moving average is $98.80.

Billiontoone (NASDAQ:BLLN) last announced its earnings results on Tuesday, December 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.06). The business had revenue of $83.52 million during the quarter, compared to analyst estimates of $82.86 million.

Institutional Investors Weigh In On Billiontoone

A hedge fund recently bought a new stake in Billiontoone stock. FNY Investment Advisers LLC purchased a new stake in Billiontoone, Inc. (NASDAQ:BLLN) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 6,080 shares of the company’s stock, valued at approximately $497,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.